KRAS and pancreatic ductal adenocarcinoma: The sequence was tested to inhibit KRAS in two pancreatic ductal adenocarcinoma cell lines, showing that the NP functionalized with TAT-Pal and 126b-Pal, respectively, induced an ~70% decrease in protein KRAS and ~40% inhibition of colony formation [86].